Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet R Vos

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 16, 2024
The heterogeneous cancer phenotype of individuals with biallelic germline pathogenic variants in CHEK2Snežana Hinić, Cezary Cybulski, Rachel S Van der Post, et al.
Journal of the National Cancer Institute|September 29, 2022
Cancer risks by sex and variant type in PTEN hamartoma tumor syndromeLinda A J Hendricks, Nicoline Hoogerbrugge, Arjen R Mensenkamp, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 28, 2025
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)Linda A J Hendricks, Katja C J Verbeek, Janneke H M Schuurs-Hoeijmakers, et al.
Cancer Cell|February 13, 2019
Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor PhenotypeJudith E Grolleman, Richarda M de Voer, Fadwa A Elsayed, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 16, 2024
The heterogeneous cancer phenotype of individuals with biallelic germline pathogenic variants in CHEK2Snežana Hinić, Cezary Cybulski, Rachel S Van der Post, et al.
Journal of the National Cancer Institute|September 29, 2022
Cancer risks by sex and variant type in PTEN hamartoma tumor syndromeLinda A J Hendricks, Nicoline Hoogerbrugge, Arjen R Mensenkamp, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 28, 2025
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)Linda A J Hendricks, Katja C J Verbeek, Janneke H M Schuurs-Hoeijmakers, et al.
Cancer Cell|February 13, 2019
Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor PhenotypeJudith E Grolleman, Richarda M de Voer, Fadwa A Elsayed, et al.
Pageof 4